1.00071

CCDA Selective Supplement

for Campylobacter spp., pkg of 10 vials, For the preparation of Campylobacter Blood Free Selective Agar

• 別名: Blood Free Campylobacter Medium Selective Supplement, Campylobacter Blood-Free Medium Selective Supplement, Campylobacter Selective Supplement
• UNSPSCコード: 41106212
• NACRES: NA.74

特性

• 認証: ISO 10272; ISO
• 品質水準: 200
• 形状: lyophilized powder
• 組成: Amphotericin B, 5 mg ; Cefoperazone, 16 mg
• 包装: pkg of 10 vials
• テクニック: microbiological culture: suitable
• pH: 7.0-7.4 (25 °C, 40 g/L in H₂O, suspension)
• 溶解性: 40 g/L
• アプリケーション: food and beverages; microbiology
• 保管温度: 2-8°C
• 適合性: Campylobacter spp.

詳細

詳細

CCDA Selective Supplement is a mixture of two antibiotics (Amphotericin B & Cefoperazone) in lyophilized form. Amphotericin B largely reduces the growth of yeasts and molds, while Cefoperazone especially inhibits the growth of Enterobacteriaceae.

アプリケーション

CCDA Selective Supplement is an additive used during the preparation of Campylobacter Blood Free Selective Agar for the enrichment of Campylobacter from foods.

関連事項

Replaces: 1.00071

アナリシスノート

Typical composition (per vial): Amphotericin B 5.0 mg; Cefoperazone 16.0 mg.

Growth promotion test in accordance with ISO 11133.
Supplement tested with base Art. 1.00070.
Growth
- Campylobacter coli ATCC 43478 (WDCM 00004):
good
- Campylobacter jejuni ATCC 33291 (WDCM 00005): good
- Campylobacter jejuni ATCC 29428 (WDCM 00156): good
- Staphylococcus aureus ATCC 25923 (WDCM 00034): no growth
- Escherichia coli ATCC 25922 (WDCM 00013): inhibited growth
- Escherichia coli ATCC 8739 (WDCM 00012): inhibited growth
Incubation: 44 hrs. 41.5 °C with Anaercult C. E.coli and Staph.aur. aerobic.
Strains tested with three-loop-streak.

安全性情報

• ピクトグラム: GHS08
• シグナルワード: Danger
• 危険有害性情報: H317 - H334 - H373
• 注意書き: P260 - P272 - P280 - P284 - P302 + P352 - P333 + P313
• 危険有害性の分類: Resp. Sens. 1 - Skin Sens. 1 - STOT RE 2
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3